Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0613820070170081082
Journal of Life Science
2007 Volume.17 No. 8 p.1082 ~ p.1089
Identification of Tumor Antigens in Lung Cancer Patient by SEREX
Min Young-Ki

Lee Min-Ki
Kim Cheol-Min
Park Young-Min
Lee Sang-Yull
Ha Jin-Mok
Son Young-Ok
Park Hae-Rim
Abstract
Serological anlysis of recombinant cDNA expression libraries (SEREX) has led to identification of several categories of new antigens recognized by the immune system of cancer patients, which are referred to as the cancer immunome. We analyzed normal testis cDNA expression libraries with serumobtained from non-small lung cancer patient and isolated 40 distinct antigen designated KP-LuT-1 through KP-LuT-40. Among these antigens 20 antigens were previously identified by SEREX analysis of other tumor types, and 20 out of 40 antigens (50%) did not match entries in Cancer Immunome Database and were considered newly identified antigens. Sequencing analysis showed that the antigens comprised 26 functional known proteins and 14 noble/uncharacterized gene products. Of these, the hypothetical protein KP-LuT-6 was shown tissue-restricted. RT-PCR showed it to be expressed strongly only in normal testis. In addition to normal tissues-restricted expression, KP-LuT-6 mRNA was detected in lung tumor samples(3/10), stomach tumor samples(3/10), and breast tumor samples(1/5), whereas not detected in colon tumor samples(0/12). These data suggest that KP-LuT-6 is a cancer/testis (CT)-like antigen as a potential target for cancer immunotherapies.
KEYWORD
SEREX, tumor antigen, cancer/testis(CT) antigen, lung cancer
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)